2 news items
Soleno Therapeutics Announces Oral Presentation Featuring DCCR Extended-Release Tablets In Prader-Willi Syndrome At ENDO 2024
SLNO
22 May 24
at the Annual Meeting of the Endocrine Society (ENDO 2024), being held June 1-4, 2024 in Boston, Massachusetts.
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
SLNO
22 May 24
presentation at the Annual Meeting of the Endocrine Society (ENDO 2024), being held June 1-4, 2024 in Boston, Massachusetts
- Prev
- 1
- Next